Abiopharma

Clinical trial NCT03162536 updates: 1. completion date: 2026-09-18 → 2027-09-17 2. primary completion date: 2026-09-18 → 2027-09-17

Clinical trial NCT03462316 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2024-05-15 → 2026-04-15 3. primary completion date: 2024-02-15 → 2020-04-15 4. enrollment: 20 → 2 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07504601: start date: 2026-06-16 → 2026-06-17.

Clinical trial NCT05475171 updates: 1. completion date: 2026-06-30 → 2028-06-30 2. primary completion date: 2026-06-30 → 2028-06-30

Clinical trial NCT05489705: enrollment: 1600 → 1700 participants.

Clinical trial NCT07471477 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-06-01 → 2026-06-06 3. primary completion date: 2026-06-01 → 2026-06-06 4. enrollment: 60 → 56 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06431022 updates: 1. completion date: 2026-05-10 → 2026-06-05 2. primary completion date: 2026-05-10 → 2026-06-05

Clinical trial NCT07578649: collaborators added: European Network of Gynaecological Oncological Trial Groups (ENGOT).

Clinical trial NCT02232516 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2024-08-01 → 2024-03-16

Clinical trial NCT07248839 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. completion date: 2026-04-06 → 2026-08-05 3. primary completion date: 2026-04-06 → 2026-08-05